Plasma biomarkers, including RAGE, Ang-2, IL-8, and sTNFR-1, can predict the development of ARDS (41, 42) and ARDS outcomes (43, 44) and classify ARDS phenotypes that are durable over time (45, 46). Here, ANGPT2 is linked to acute respiratory distress syndrome.